BioWorld

Feb. 18, 2004

View Archived Issues

Excavated American, British, Dutch Avian Influenza Molecules Explicate 1918-19 Worldwide Human Pandemic

Read More

CollaGenex's Periostat Shown Effective In Rosacea Phase III

Read More

Other News To Note

Read More

Cortex's Ampakine CX516 Fizzles, But More Potent Ones In Pipeline

Cortex Pharmaceuticals Inc.'s CX516 for mild cognitive impairment failed to meet its primary endpoint in a Phase IIb trial, although a subset of patients with the worst memory trouble showed improvement over placebo. (BioWorld Today) Read More

Anticipating Greater Spending For Trials, BioCryst Brings In $21.4M

Read More